Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jan 5;7(1):e013634.
doi: 10.1136/bmjopen-2016-013634.

EpideMiology and control measures of outBreaks due to Antibiotic-Resistant orGanisms in EurOpe (EMBARGO): a systematic review protocol

Nithya Babu Rajendran  1 , Beryl Primrose Gladstone  1 , Jesús Rodríguez-Baño  2 , Frangiscos Sifakis  3 , Andreas Voss  4   5 , Yehuda Carmeli  6 , Francesco Robert Burkert  1 , Panagiota Gkolia  1 , Evelina Tacconelli  1
Affiliations

EpideMiology and control measures of outBreaks due to Antibiotic-Resistant orGanisms in EurOpe (EMBARGO): a systematic review protocol

Nithya Babu Rajendran et al. BMJ Open. .

Erratum in

Abstract

Introduction: Improving our understanding of outbreaks due to antibiotic-resistant bacteria (ARB) and their control is critical in the current public health scenario. The threat of outbreaks due to ARB requires multifaceted efforts. However, a global overview of epidemiological characteristics of outbreaks due to ARB and effective infection control measures is missing. In this paper, we describe the protocol of a systematic review aimed at mapping and characterising the epidemiological aspects of outbreaks due to ARB and infection control measures in European countries.

Methods and analysis: The databases MEDLINE, Web of Knowledge and Cochrane library will be searched using a 3-step search strategy. Selection of articles for inclusion will be performed by 2 reviewers using predefined eligibility criteria. All study designs will be included if they report an outbreak and define the microbiological methods used for microorganism identification. The target bacteria will be methicillin-resistant and vancomycin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, ceftazidime-resistant and carbapenem-resistant Acinetobacter baumannii, ceftazidime-resistant and carbapenem-resistant Pseudomonas aeruginosa, ciprofloxacin-resistant Escherichia coli, extended-spectrum β-lactamase-producing E. coli and Klebsiella pneumoniae, carbapenem-resistant and carbapenamase-producing Enterobacteriaceae. Data will be extracted using a tailored pilot tested form and the quality of reporting will be assessed using the ORION (Outbreak Reports and Intervention Studies Of Nosocomial infections) tool. Data will be synthesised and reported by the type of ARB, setting and country. Infection control measures and bundles of measures will be described. The effectiveness will be reported as defined by the authors. Regression analysis will be used to define independent factors associated with outbreaks' control. Heterogeneity between studies will be assessed by forest plots and I² statistics.

Ethics and dissemination: Ethical approval is not applicable for this study. Findings will be disseminated through journal publication and conference presentations and talks.

Keywords: EPIDEMIOLOGY; antimicrobial resistance; outbreak.

PubMed Disclaimer

Conflict of interest statement

FS is an employee of AstraZeneca, an EFPIA (European Federation of Pharmaceutical Industries and Association) member company in the IMI JU and costs related to his research contributions were covered by AstraZeneca as in-kind contribution under the IMI JU agreement.

References

    1. Wright GD. The antibiotic resistome: the nexus of chemical and genetic diversity. Nat Rev Microbiol 2007;5:175–86. 10.1038/nrmicro1614 - DOI - PubMed
    1. Davies J, Davies D. Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev 2010;74:417–33. 10.1128/MMBR.00016-10 - DOI - PMC - PubMed
    1. Tacconelli E, De Angelis G, Cataldo MA et al. . Antibiotic usage and risk of colonization and infection with antibiotic-resistant bacteria: a hospital population-based study. Antimicrob Agents Chemother 2009;53:4264–9. 10.1128/AAC.00431-09 - DOI - PMC - PubMed
    1. Brown ED, Wright GD. Antibacterial drug discovery in the resistance era. Nature 2016;529:336–43. 10.1038/nature17042 - DOI - PubMed
    1. Schroder W, Sommer H, Gladstone BP et al. . Gender differences in antibiotic prescribing in the community: a systematic review and meta-analysis. J Antimicrob Chemother 2016;71:1800–6. 10.1093/jac/dkw054 - DOI - PubMed

MeSH terms